Seres Therapeutics Revenue, Growth & Competitor Profile

DBA SERES HEALTH, INC.

Company Profile & Annual Report for Seres Therapeutics

Access the complete profile.

Seres Therapeutics Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	517 Telecommunications
Address	200, Sidney Street Cambridge, MA 02139

Seres Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Seres Therapeutics's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Seres Therapeutics is classified as operating in the Telecommunications industry, NAICS Code 517.

Seres Therapeutics is a publicly traded company on NMS using the ticker symbol MCRB. Detailed information on company financials and operating reports can be found here: NMS: MCRB

Seres Therapeutics Annual Revenue and Growth Rate

Seres Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Seres Therapeutics's revenues are gauged from an analysis of company filings.

Investor Activity

Seres Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
January 5, 2015	1	100%	$65 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Seres Therapeutics is developing and marketing. Seres Therapeutics doesn't have any recent trademark applications, indicating Seres Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
VOWST VOYAGE Educational services, namely, conducting educational programs in the fields of dysbiosis and other medical conditions resulting from a disturbed microbial community and treatment and patient support options for these conditions	03/08/2023
CDOWST Pharmaceuticals used to maintain health or restore health to a human subject via treatment of a disturbed microbial community, namely, for the treatment of dysbiosis and clostridium difficile; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject via treatment of a disturbed microbial community, namely, for the treatment of dysbiosis and clostridium difficile; cultures and preparations of microorganisms for medical purposes; pharmaceuticals and biological preparations used to prevent and treat dysbiosis and other medical conditions resulting from a disturbed microbial community	10/14/2020
CDRUPTEV Pharmaceuticals used to maintain health or restore health to a human subject via treatment of a disturbed microbial community, namely, for the treatment of dysbiosis and clostridium difficile; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject via treatment of a disturbed microbial community, namely, for the treatment of dysbiosis and clostridium difficile; cultures and preparations of microorganisms for medical purposes; pharmaceuticals and biological preparations used to prevent and treat dysbiosis and other medical conditions resulting from a disturbed microbial community	10/14/2020

See all trademarks and details in the Full Report.

Market Share of Seres Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Seres Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AT & T	Dallas, TX	100
VERIZON COMMUNICATIONS	New York, NY	57
CCO HOLDINGS	Saint Louis, MO	55
T-MOBILE USA	Bellevue, WA	46
QUALCOMM	San Diego, CA	38
DIRECTV	El Segundo, CA	34
CENTURYLINK COMMUNICATIONS	Monroe, LA	15
NATIONAL TELECOMMUNICATIONS COOPERATIVE ASSOCIATION	Arlington, VA	13

Nearby Competitors

These companies are similar in business line and location to Seres Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
GRANITE TELECOMMUNICATIONS	Quincy, MA	100
SERES THERAPEUTICS	Cambridge, MA	21
STARRY	Boston, MA	10
COMNISCIENT TECHNOLOGIES	Boston, MA	8
TIVE	Charlestown, MA	5
ALTAEROS ENERGIES	Somerville, MA	2

Future Competition: Seres Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Seres Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)